Santen has announced that the European Commission has granted market authorisation for Ryjunea, a low-dose atropine eye drop ...

Birmingham spin-out Linear Diagnostics has secured £1m funding to advance a rapid test for sexually transmitted infections ...

Flip feasibility: from capacity and capability to human realities True feasibility begins with understanding the patient.

Sogroya acts as a replacement for endogenous growth hormone and is administered once a week to support growth in children ...

Richard Condon, CEO Aspire Pharma, discusses successful leadership ...

As Europe’s adoption of the IDMP data model advances, EMA’s centralised Product Management Services (PMS) platform is coming ...

The great NHS prescribing lottery. Imagine a patient in Manchester receiving a cutting-edge medication, while another in ...

Over the past two decades, clinical trials have undergone significant transformation. Historically, trials followed a ...

The recent landmark ruling by the UK’s Supreme Court – that the term “sex” in the Equality Act 2010 refers to biological sex, ...

In a sector defined by innovation, evidence and outcomes, the true catalyst for transformation is often overlooked: ...

The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...